Mortalidad por cáncer en Chile: consideraciones epidemiológicas

Malignancies are the second most important cause of mortality in Chile, accounting for 21.8% of total deaths. In comparison with other causes, cancer mortality shows an upward trend with increasing mortality rates from 99 to 118 per 100.000 population in the period 1980-1998. The most important canc...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Medina L,Ernesto, Kaempffer R,Ana M
Lenguaje:Spanish / Castilian
Publicado: Sociedad Médica de Santiago 2001
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872001001000014
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0034-98872001001000014
record_format dspace
spelling oai:scielo:S0034-988720010010000142005-11-14Mortalidad por cáncer en Chile: consideraciones epidemiológicasMedina L,ErnestoKaempffer R,Ana M Neoplasms Mortality Epidemiologic factors Malignancies are the second most important cause of mortality in Chile, accounting for 21.8% of total deaths. In comparison with other causes, cancer mortality shows an upward trend with increasing mortality rates from 99 to 118 per 100.000 population in the period 1980-1998. The most important cancer locations are stomach, lung and prostate among men and gallbladder, stomach, breast and uterine cervix in women. According to present risks, the mean probability for a Chilean to die from cancer is 3.0% for stomach, 2.3% for prostate, 2.0% for lung, 1.7% for gallbladder, 1.6% for breast and 1.2% for uterine cervix cancer. Recent trends of cancer crude death rates are a matter of concern. During the period 1990-1998 a significant decrease of death rates was only noticed for uterine cervix cancers. On the other hand, important increases were observed for prostate, lung, gallbladder, colon and kidney cancers. If death rates are adjusted by age, an increased risk, not due to the population aging process, is noticed for prostate and to less extent for kidney, colon, skin and myeloma. The adjusted rates show a downward trend for uterine cervix, stomach, breast and esophagus cancer. Increasing cancer mortality is associated with diagnostic and therapeutic delays. Possible actions in screening programs are discussed (Rev Méd Chile 2001; 129: 1195-1202).info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.129 n.10 20012001-10-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872001001000014es10.4067/S0034-98872001001000014
institution Scielo Chile
collection Scielo Chile
language Spanish / Castilian
topic Neoplasms
Mortality
Epidemiologic factors
spellingShingle Neoplasms
Mortality
Epidemiologic factors
Medina L,Ernesto
Kaempffer R,Ana M
Mortalidad por cáncer en Chile: consideraciones epidemiológicas
description Malignancies are the second most important cause of mortality in Chile, accounting for 21.8% of total deaths. In comparison with other causes, cancer mortality shows an upward trend with increasing mortality rates from 99 to 118 per 100.000 population in the period 1980-1998. The most important cancer locations are stomach, lung and prostate among men and gallbladder, stomach, breast and uterine cervix in women. According to present risks, the mean probability for a Chilean to die from cancer is 3.0% for stomach, 2.3% for prostate, 2.0% for lung, 1.7% for gallbladder, 1.6% for breast and 1.2% for uterine cervix cancer. Recent trends of cancer crude death rates are a matter of concern. During the period 1990-1998 a significant decrease of death rates was only noticed for uterine cervix cancers. On the other hand, important increases were observed for prostate, lung, gallbladder, colon and kidney cancers. If death rates are adjusted by age, an increased risk, not due to the population aging process, is noticed for prostate and to less extent for kidney, colon, skin and myeloma. The adjusted rates show a downward trend for uterine cervix, stomach, breast and esophagus cancer. Increasing cancer mortality is associated with diagnostic and therapeutic delays. Possible actions in screening programs are discussed (Rev Méd Chile 2001; 129: 1195-1202).
author Medina L,Ernesto
Kaempffer R,Ana M
author_facet Medina L,Ernesto
Kaempffer R,Ana M
author_sort Medina L,Ernesto
title Mortalidad por cáncer en Chile: consideraciones epidemiológicas
title_short Mortalidad por cáncer en Chile: consideraciones epidemiológicas
title_full Mortalidad por cáncer en Chile: consideraciones epidemiológicas
title_fullStr Mortalidad por cáncer en Chile: consideraciones epidemiológicas
title_full_unstemmed Mortalidad por cáncer en Chile: consideraciones epidemiológicas
title_sort mortalidad por cáncer en chile: consideraciones epidemiológicas
publisher Sociedad Médica de Santiago
publishDate 2001
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872001001000014
work_keys_str_mv AT medinalernesto mortalidadporcancerenchileconsideracionesepidemiologicas
AT kaempfferranam mortalidadporcancerenchileconsideracionesepidemiologicas
_version_ 1718435997777133568